US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aspire Biopharma Holdings Inc.

0.3825

+0.00611.62%

Post-market: 0.3814-0.0011-0.29%16:55 EDT

Volume:1.86M

Turnover:701.21K

Market Cap:18.94M

PE:-1.00

High:0.3967

Open:0.3890

Low:0.3540

Close:0.3764

52wk High:15.80

52wk Low:0.2012

Shares:49.53M

Float Shares:35.35M

Volume Ratio:0.52

T/O Rate:5.27%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3817

EPS(LYR):-0.0030

ROE:--

ROA:-64.24%

PB:-1.97

PE(LYR):-128.53

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Aspire Biopharma Faces Nasdaq Delisting After Compliance Failures

Aspire Biopharma Holdings Announces Breakthrough in Sublingual Drug Delivery with New Patent Application

Aspire Biopharma Holdings Inc. to Present Pipeline Updates at Noble Capital Markets Emerging Growth Virtual Equity Conference

Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ASBP"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","market":"US","secType":"STK","nameCN":"Aspire Biopharma Holdings Inc.","latestPrice":0.3825,"timestamp":1761940800000,"preClose":0.3764,"halted":0,"volume":1864114,"hourTrading":{"tag":"盘后","latestPrice":0.3814,"preClose":0.3825,"latestTime":"16:55 EDT","volume":2210,"amount":851.68538,"timestamp":1761944124249},"delay":0,"floatShares":35345600,"shares":49525970,"eps":-0.38171,"marketStatus":"Post-Mkt","change":0.0061,"latestTime":"10-31 16:57:03 EDT","open":0.389,"high":0.3967,"low":0.354,"amount":701210.9941991,"amplitude":0.113443,"askPrice":0.3908,"askSize":5,"bidPrice":0.3521,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.38171,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1761955200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.3764,"preHourTrading":{"tag":"盘前","latestPrice":0.3899,"preClose":0.3764,"latestTime":"09:29 EDT","volume":89267,"amount":34097.1731628,"timestamp":1761917382036},"postHourTrading":{"tag":"盘后","latestPrice":0.3814,"preClose":0.3825,"latestTime":"16:55 EDT","volume":2210,"amount":851.68538,"timestamp":1761944124249},"volumeRatio":0.516688},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","floatShares":35345600,"roa":"-64.24%","roe":"--","lyrEps":-0.002976,"volumeRatio":0.516688,"shares":49525970,"dividePrice":0,"high":0.3967,"amplitude":0.113443,"preClose":0.3764,"low":0.354,"week52Low":0.2012,"pbRate":"-1.97","week52High":15.8,"institutionHeld":0,"latestPrice":0.3825,"committee":0.99005,"eps":-0.38171,"divideRate":0,"volume":1864114,"delay":0,"ttmEps":-0.38171,"open":0.389,"prevYearClose":11.5,"prevWeekClose":0.3443,"prevMonthClose":0.206,"prevQuarterClose":0.206,"fiveDayClose":0.3443,"twentyDayClose":0.3838,"sixtyDayClose":0.3334},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASBP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASBP","date":"2025-10-30","current":-0.986089,"percent":0.654762,"low":-107.647863,"twenty":-36.496931,"median":-1.153491,"eighty":-0.912062,"high":-0.539675,"avg":-13.724862,"sd":20.38052,"marketCap":19513232},"quantilePoints":[{"date":"2025-03-07","current":-61.718107,"twenty":-79.515888,"median":-61.718107,"eighty":-58.474317,"marketCap":40003023},{"date":"2025-03-14","current":-41.62384,"twenty":-63.871064,"median":-57.344015,"eighty":-54.828644,"marketCap":26978783},{"date":"2025-03-21","current":-49.388839,"twenty":-61.718107,"median":-55.259235,"eighty":-45.464716,"marketCap":32011722},{"date":"2025-03-28","current":-47.36506,"twenty":-59.766092,"median":-48.376949,"eighty":-45.613987,"marketCap":30699995},{"date":"2025-04-04","current":-38.75323,"twenty":-56.183571,"median":-46.367595,"eighty":-43.647619,"marketCap":25118177},{"date":"2025-04-11","current":-38.035578,"twenty":-55.34679,"median":-45.929755,"eighty":-40.946376,"marketCap":24653026},{"date":"2025-04-17","current":-39.57853,"twenty":-55.287942,"median":-45.474044,"eighty":-39.546954,"marketCap":25653101},{"date":"2025-04-25","current":-36.428037,"twenty":-53.967461,"median":-44.487272,"eighty":-38.006872,"marketCap":23611087},{"date":"2025-05-02","current":-25.763721,"twenty":-50.875815,"median":-42.879731,"eighty":-36.06634,"marketCap":16698936},{"date":"2025-05-09","current":-24.070062,"twenty":-48.174572,"median":-41.62384,"eighty":-32.456117,"marketCap":15601179},{"date":"2025-05-16","current":-8.64997,"twenty":-47.360753,"median":-40.170558,"eighty":-27.896584,"marketCap":11330354},{"date":"2025-05-23","current":-0.643502,"twenty":-46.76371,"median":-38.75323,"eighty":-25.110657,"marketCap":10952545},{"date":"2025-05-30","current":-1.730761,"twenty":-46.192459,"median":-37.963813,"eighty":-23.557658,"marketCap":29457944},{"date":"2025-06-06","current":-0.976857,"twenty":-45.929755,"median":-36.514155,"eighty":-4.677726,"marketCap":16626329},{"date":"2025-06-13","current":-1.091781,"twenty":-45.929755,"median":-34.956848,"eighty":-1.13913,"marketCap":18582368},{"date":"2025-06-20","current":-0.913361,"twenty":-45.88526,"median":-32.509654,"eighty":-1.103849,"marketCap":15545618},{"date":"2025-06-27","current":-0.879171,"twenty":-45.613987,"median":-30.966702,"eighty":-1.056614,"marketCap":14963696},{"date":"2025-07-03","current":-0.838948,"twenty":-45.240807,"median":-27.672677,"eighty":-0.926003,"marketCap":14279083},{"date":"2025-07-11","current":-0.994957,"twenty":-44.49445,"median":-25.763721,"eighty":-0.89957,"marketCap":16934405},{"date":"2025-07-18","current":-1.022827,"twenty":-44.487272,"median":-24.235121,"eighty":-0.913361,"marketCap":17408745},{"date":"2025-07-25","current":-1.492005,"twenty":-43.705031,"median":-23.47441,"eighty":-0.913361,"marketCap":25394273},{"date":"2025-08-01","current":-1.094942,"twenty":-43.417971,"median":-12.855253,"eighty":-0.926003,"marketCap":18636159},{"date":"2025-08-08","current":-0.957894,"twenty":-42.341491,"median":-1.730761,"eighty":-0.926003,"marketCap":16303583},{"date":"2025-08-15","current":-1.119076,"twenty":-41.810429,"median":-1.408829,"eighty":-0.936633,"marketCap":19046927},{"date":"2025-08-22","current":-1.407348,"twenty":-41.62384,"median":-1.381965,"eighty":-0.948126,"marketCap":26605351},{"date":"2025-08-29","current":-1.458172,"twenty":-41.494663,"median":-1.401585,"eighty":-0.950712,"marketCap":27566154},{"date":"2025-09-05","current":-1.427258,"twenty":-40.909001,"median":-1.428961,"eighty":-0.956458,"marketCap":26981748},{"date":"2025-09-12","current":-1.182832,"twenty":-39.815341,"median":-1.395821,"eighty":-0.96387,"marketCap":22360975},{"date":"2025-09-19","current":-1.153491,"twenty":-39.515377,"median":-1.375367,"eighty":-0.974558,"marketCap":21806284},{"date":"2025-09-26","current":-0.990278,"twenty":-38.902502,"median":-1.341067,"eighty":-0.987594,"marketCap":18720816},{"date":"2025-10-03","current":-1.100309,"twenty":-38.179108,"median":-1.232741,"eighty":-0.956458,"marketCap":20800907},{"date":"2025-10-10","current":-0.881819,"twenty":-37.978166,"median":-1.192915,"eighty":-0.950195,"marketCap":16670441},{"date":"2025-10-17","current":-0.836759,"twenty":-37.504515,"median":-1.176427,"eighty":-0.934507,"marketCap":15818594},{"date":"2025-10-24","current":-0.880247,"twenty":-36.758157,"median":-1.164494,"eighty":-0.913361,"marketCap":16640725},{"date":"2025-10-30","current":-1.032195,"twenty":-36.496931,"median":-1.153491,"eighty":-0.912062,"marketCap":19513232}],"updateTime":1761902372359},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ASBP\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2576064128","title":"Aspire Biopharma Faces Nasdaq Delisting After Compliance Failures","url":"https://stock-news.laohu8.com/highlight/detail?id=2576064128","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576064128?lang=en_us&edition=fundamental","pubTime":"2025-10-18 05:16","pubTimestamp":1760735780,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc. has announced that it received a notice from the Nasdaq Stock Market LLC regarding its failure to comply with two key listing requirements: the minimum Market Value of Listed Securities  of $50 million and the minimum bid price rule. The company did not regain compliance within the designated 180-day period, leading Nasdaq staff to notify Aspire that its securities are subject to delisting. Aspire has requested a hearing before the Nasdaq Hearings Panel, which temporarily stays the suspension of its common stock and warrants. The company will present its plan to regain compliance and seek an extension, but there is no assurance that continued listing will be granted or that compliance will be achieved in the allotted time.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL2WX1n6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"gpt_icon":0},{"id":"2573672268","title":"Aspire Biopharma Holdings Announces Breakthrough in Sublingual Drug Delivery with New Patent Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2573672268","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573672268?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:30","pubTimestamp":1759753832,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc. has announced the filing of an omnibus patent application with the U.S. Patent and Trademark Office for its innovative sublingual drug delivery platform. The proprietary technology, which has not yet been presented at scientific conferences, is designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients  by enabling rapid absorption through sublingual blood vessels. Key features of the platform include faster onset of action, reduced drug-food and drug-drug interactions, lower risk of gastrointestinal irritation, and ease of administration, particularly in emergency situations. Aspire believes this advancement could significantly improve the efficacy and safety of a wide range of medications.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shoul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL2CxrC9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"gpt_icon":0},{"id":"2572686796","title":"Aspire Biopharma Holdings Inc. to Present Pipeline Updates at Noble Capital Markets Emerging Growth Virtual Equity Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2572686796","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572686796?lang=en_us&edition=fundamental","pubTime":"2025-10-03 23:30","pubTimestamp":1759505417,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc. to Present Pipeline Updates at Noble Capital Markets Emerging Growth Virtual Equity Conference. Aspire Biopharma Holdings Inc. will participate in the Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference on October 8-9, 2025. The company will present updates on its disruptive sublingual drug delivery technology, including its lead programs targeting FDA submission for sublingual high-dose aspirin and a sublingual ED medication in the second half of 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire  on October 03, 2025, and is solely responsible for the information contained","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL1ylrTt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"gpt_icon":0},{"id":"2572868547","title":"Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2572868547","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572868547?lang=en_us&edition=fundamental","pubTime":"2025-10-03 02:44","pubTimestamp":1759430656,"startTime":"0","endTime":"0","summary":"U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.2% on Thursday.\n\n\n\nThe Dow traded up 0.20% to 46,532.02 while the NASDAQ rose 0.34% to 22,833.17. The S&amp;P 500 also rose, gaining, 0.07% to 6,715.87.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/10/48002933/crude-oil-down-2-aspire-biopharma-shares-spike-higher","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain","BK4600","NVNI","TQQQ","USAW.SI","TSYW.SI","BK4170","BK4007","BK4164","BK4603","BK4144","USJW.SI","ANGO","QLD","BK4595","NVIW.SI","FPAY","PSQ","UFG","ASBP","BK4526","SQQQ",".IXIC","MNQmain","BK4020","BK4082","BK4023","QID"],"gpt_icon":1}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ASBP\",params:#limit:6,delay:false,,,undefined,":[]}}